Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stroke

  Free Subscription

Articles published in
Lancet Neurol
    September 2021
  1. PANDIAN JD, Sebastian IA
    Integrated approach to stroke burden: are we doing enough?
    Lancet Neurol. 2021 Sep 3. pii: S1474-4422(21)00287.
    >> Share


  2. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet Neurol. 2021 Sep 3. pii: S1474-4422(21)00252.
    >> Share

  3. CASO V, Mosconi MG
    Lessons to be learned in intracerebral haemorrhage research.
    Lancet Neurol. 2021 Sep 2. pii: S1474-4422(21)00296.
    >> Share

  4. HOWARD DPJ, Rothwell PM
    Asymptomatic carotid stenosis and stroke risk - Authors' reply.
    Lancet Neurol. 2021;20:699.
    >> Share

  5. ABBOTT A
    Asymptomatic carotid stenosis and stroke risk.
    Lancet Neurol. 2021;20:698-699.
    >> Share

  6. ROTHWELL PM, Buchan AM
    A new thrombolytic drug for acute ischaemic stroke.
    Lancet Neurol. 2021;20:687-689.
    >> Share

  7. GUSEV EI, Martynov MY, Nikonov AA, Shamalov NA, et al
    Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Lancet Neurol. 2021;20:721-728.
    >> Share

    July 2021
  8. BANDINI F, Vestito L, Filippi L
    Prehospital scales in acute ischaemic stroke management.
    Lancet Neurol. 2021;20:504.
    >> Share

  9. DUVEKOT MHC, Venema E, Kerkhoff H, Dippel DWJ, et al
    Prehospital scales in acute ischaemic stroke management - Authors' reply.
    Lancet Neurol. 2021;20:504-505.
    >> Share

    June 2021
  10. LI L, Poon MTC, Samarasekera NE, Perry LA, et al
    Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.
    Lancet Neurol. 2021;20:437-447.
    >> Share

  11. HAEUSLER KG, Kirchhof P, Kunze C, Tutuncu S, et al
    Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study.
    Lancet Neurol. 2021;20:426-436.
    >> Share

  12. CHENG X, Dong Q
    Towards individualised secondary prevention after intracerebral haemorrhage.
    Lancet Neurol. 2021;20:411-413.
    >> Share

  13. WASSERLAUF J, Volgman AS
    Monitoring for atrial fibrillation after stroke.
    Lancet Neurol. 2021;20:410-411.
    >> Share

    May 2021
  14. JORDAN LC, DeBaun MR, Donahue MJ
    Advances in neuroimaging to improve care in sickle cell disease.
    Lancet Neurol. 2021;20:398-408.
    >> Share

  15. HACHINSKI V, Avan A, Gilliland J, Oveisgharan S, et al
    A new definition of brain health.
    Lancet Neurol. 2021;20:335-336.
    >> Share

    April 2021
  16. WEAVER NA, Kuijf HJ, Aben HP, Abrigo J, et al
    Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts.
    Lancet Neurol. 2021 Apr 23. pii: S1474-4422(21)00060.
    >> Share

  17. PANTONI L, Salvadori E
    Location of infarcts and post-stroke cognitive impairment.
    Lancet Neurol. 2021 Apr 23. pii: S1474-4422(21)00107.
    >> Share

  18. BEST JG, Ambler G, Wilson D, Lee KJ, et al
    Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from
    Lancet Neurol. 2021;20:294-303.
    >> Share

  19. GREENBERG SM
    Cerebral microbleeds and prediction of intracranial haemorrhage.
    Lancet Neurol. 2021;20:252-254.
    >> Share

  20. ZIAI WC, Al-Kawaz M
    Blood pressure management after endovascular therapy.
    Lancet Neurol. 2021;20:248-249.
    >> Share

  21. LAUMANN TO, Ortega M, Hoyt CR, Seider NA, et al
    Brain network reorganisation in an adolescent after bilateral perinatal strokes.
    Lancet Neurol. 2021;20:255-256.
    >> Share

    March 2021
  22. SCHMIDT R, Hofer E
    Identifying novel genetic risk loci for lacunar stroke.
    Lancet Neurol. 2021 Mar 25. pii: S1474-4422(21)00099.
    >> Share

  23. TRAYLOR M, Persyn E, Tomppo L, Klasson S, et al
    Genetic basis of lacunar stroke: a pooled analysis of individual patient data and genome-wide association studies.
    Lancet Neurol. 2021 Mar 25. pii: S1474-4422(21)00031.
    >> Share

  24. ENGELTER ST, Traenka C, Gensicke H, Schaedelin SA, et al
    Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
    Lancet Neurol. 2021 Mar 22. pii: S1474-4422(21)00044.
    >> Share

  25. HOWARD DPJ, Gaziano L, Rothwell PM
    Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis.
    Lancet Neurol. 2021;20:193-202.
    >> Share

  26. VAN DIJCK JTJM, Kompanje EJO, Nederkoorn PJ, Peul WC, et al
    Advanced consent for acute stroke trials - Authors' reply.
    Lancet Neurol. 2021;20:170-171.
    >> Share

  27. SHAMY M, Dewar B, Niznick N, Nicholls S, et al
    Advanced consent for acute stroke trials.
    Lancet Neurol. 2021;20:170.
    >> Share

  28. SPENCE JD
    Treatment of asymptomatic carotid stenosis.
    Lancet Neurol. 2021;20:163-165.
    >> Share

    February 2021
  29. MAZIGHI M, Richard S, Lapergue B, Sibon I, et al
    Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2021 Feb 26. pii: S1474-4422(20)30483.
    >> Share

    January 2021
  30. DUVEKOT MHC, Venema E, Rozeman AD, Moudrous W, et al
    Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30439.
    >> Share

  31. GOYAL M, Marko M
    Optimising prehospital stroke triage in a changing landscape.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30488.
    >> Share

  32. TSIVGOULIS G, Katsanos AH
    Important advances in stroke research in 2020.
    Lancet Neurol. 2021;20:2-3.
    >> Share

    December 2020
  33. WU S, Anderson CS
    Healthy eating for secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30450.
    >> Share

  34. ENGLISH C, MacDonald-Wicks L, Patterson A, Attia J, et al
    The role of diet in secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30433.
    >> Share

  35. SILBERGLEIT R, Dickert NW
    Context and principles must drive alternatives to consent in emergency research.
    Lancet Neurol. 2020;19:968-969.
    >> Share

    November 2020
  36. THE LANCET NEUROLOGY
    A unified European action plan on stroke.
    Lancet Neurol. 2020 Nov 6. pii: S1474-4422(20)30409.
    >> Share

    October 2020
  37. MERETOJA A, Yassi N, Wu TY, Churilov L, et al
    Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2020 Oct 28. pii: S1474-4422(20)30369.
    >> Share

  38. KOMPANJE EJO, van Dijck JTJM, Chalos V, van den Berg SA, et al
    Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke.
    Lancet Neurol. 2020 Oct 21. pii: S1474-4422(20)30276.
    >> Share

    September 2020
  39. FIFI JT, Mocco J
    COVID-19 related stroke in young individuals.
    Lancet Neurol. 2020;19:713-715.
    >> Share

    August 2020

  40. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:661-669.
    >> Share


  41. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:651-660.
    >> Share

  42. KWAKKEL G, Meskers C, Ward NS
    Time for the next stage of stroke recovery trials.
    Lancet Neurol. 2020;19:636-637.
    >> Share

    July 2020
  43. FASSBENDER K, Walter S, Grunwald IQ, Merzou F, et al
    Prehospital stroke management in the thrombectomy era.
    Lancet Neurol. 2020;19:601-610.
    >> Share

  44. MOHR JP, Overbey JR, Hartmann A, Kummer RV, et al
    Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
    Lancet Neurol. 2020;19:573-581.
    >> Share

    May 2020
  45. HURFORD R, Wolters FJ, Li L, Lau KK, et al
    Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study.
    Lancet Neurol. 2020;19:413-421.
    >> Share

  46. HERMANN DM, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Refining endpoints for stroke recovery trials.
    Lancet Neurol. 2020;19:381-382.
    >> Share

  47. UCHIYAMA S
    Intensive medical management of intracranial arterial stenosis.
    Lancet Neurol. 2020;19:371-373.
    >> Share

  48. THE LANCET NEUROLOGY
    The fight against stroke must go on.
    Lancet Neurol. 2020;19:369.
    >> Share

  49. MORGAN J
    Werner Hacke: a new era for stroke patients.
    Lancet Neurol. 2020;19:387.
    >> Share

    March 2020
  50. CHABRIAT H, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Safety and efficacy of GABAA alpha5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet Neurol. 2020;19:226-233.
    >> Share

  51. CRAMER SC
    Issues important to the design of stroke recovery trials.
    Lancet Neurol. 2020;19:197-198.
    >> Share

  52. GOYAL M, Ospel J
    Challenges to stroke care 5 years after endovascular therapy became the standard.
    Lancet Neurol. 2020;19:210-211.
    >> Share

    January 2020
  53. STINEAR CM, Lang CE, Zeiler S, Byblow WD, et al
    Advances and challenges in stroke rehabilitation.
    Lancet Neurol. 2020 Jan 28. pii: S1474-4422(19)30415.
    >> Share

  54. WU S, Cheng Y, Wu B, Liu M, et al
    Stroke research in 2019: towards optimising treatment and prevention.
    Lancet Neurol. 2020;19:2-3.
    >> Share

    December 2019
  55. SCHONEWILLE WJ
    BEST evidence on mechanical thrombectomy for patients with vertebrobasilar occlusion.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30477.
    >> Share

  56. LIU X, Dai Q, Ye R, Zi W, et al
    Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30395.
    >> Share

    November 2019
  57. AHMADI M, Laumeier I, Ihl T, Steinicke M, et al
    A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30369.
    >> Share

  58. LI L
    Support programme for secondary prevention of stroke: inspiration to continue?
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30410.
    >> Share

  59. BAYONA-ORTIZ H, Useche JN, Yanez N, Velasco SC, et al
    Availability of stroke units in Colombia.
    Lancet Neurol. 2019;18:988.
    >> Share

    October 2019
  60. THE LANCET NEUROLOGY
    Global prevention of stroke: focus on the individual?
    Lancet Neurol. 2019;18:903.
    >> Share

    September 2019
  61. MOULLAALI TJ, Wang X, Martin RH, Shipes VB, et al
    Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data.
    Lancet Neurol. 2019;18:857-864.
    >> Share

  62. FLOEL A
    Computerised speech and language therapy in post-stroke aphasia.
    Lancet Neurol. 2019;18:806-807.
    >> Share

  63. PALMER R, Dimairo M, Cooper C, Enderby P, et al
    Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
    Lancet Neurol. 2019;18:821-833.
    >> Share

    July 2019
  64. SHI K, Tian DC, Li ZG, Ducruet AF, et al
    Global brain inflammation in stroke.
    Lancet Neurol. 2019 Jul 8. pii: S1474-4422(19)30078.
    >> Share

  65. SAPOSNIK G, Hachinski V
    The pathway towards an effective reduction of stroke burden worldwide: teamwork.
    Lancet Neurol. 2019;18:622-623.
    >> Share

    June 2019
  66. TOYODA K, Uchiyama S, Yamaguchi T, Easton JD, et al
    Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2019;18:539-548.
    >> Share

  67. HILL MD, Benavente OR
    The uncertain role for phosphodiesterase inhibitors in stroke prevention.
    Lancet Neurol. 2019;18:515-517.
    >> Share

  68. STINEAR CM
    Dopamine for motor recovery after stroke: where to from here?
    Lancet Neurol. 2019;18:514-515.
    >> Share

  69. FORD GA, Bhakta BB, Cozens A, Hartley S, et al
    Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2019;18:530-538.
    >> Share

  70. THE LANCET NEUROLOGY
    Adding stroke to the political agenda in Europe.
    Lancet Neurol. 2019;18:513.
    >> Share

    May 2019
  71. WILSON D, Ambler G, Lee KJ, Lim JS, et al
    Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30197.
    >> Share

  72. TSIVGOULIS G, Katsanos AH
    Can cerebral microbleeds predict stroke recurrence?
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30194.
    >> Share

  73. AL-SHAHI SALMAN R, Minks DP, Mitra D, Rodrigues MA, et al
    Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30184.
    >> Share

  74. CHRISTENSEN H
    Antiplatelets after intracerebral haemorrhage: treat the patient, not the brain imaging.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30189.
    >> Share

    April 2019
  75. OURIQUES MARTINS SC, Sacks C, Hacke W, Brainin M, et al
    Priorities to reduce the burden of stroke in Latin American countries.
    Lancet Neurol. 2019 Apr 24. pii: S1474-4422(19)30068.
    >> Share

  76. DICHGANS M, Pulit SL, Rosand J
    Stroke genetics: discovery, biology, and clinical applications.
    Lancet Neurol. 2019 Apr 8. pii: S1474-4422(19)30043.
    >> Share

  77. SABA L, Saam T, Jager HR, Yuan C, et al
    Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications.
    Lancet Neurol. 2019 Apr 3. pii: S1474-4422(19)30035.
    >> Share

  78. ALEXANDROV AV, Kohrmann M, Soinne L, Tsivgoulis G, et al
    Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
    Lancet Neurol. 2019;18:338-347.
    >> Share

  79. GAUBERTI M
    Reperfusion in acute ischaemic stroke by sonothrombolysis.
    Lancet Neurol. 2019;18:320-321.
    >> Share

  80. BRAININ M
    Stroke epidemiology in China: which are the next steps?
    Lancet Neurol. 2019;18:325-326.
    >> Share

  81. WU S, Wu B, Liu M, Chen Z, et al
    Stroke in China: advances and challenges in epidemiology, prevention, and management.
    Lancet Neurol. 2019;18:394-405.
    >> Share

    March 2019

  82. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30034.
    >> Share

  83. GORELICK PB
    The global burden of stroke: persistent and disabling.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30030.
    >> Share

  84. OGAWA A, Toyoda K, Kitagawa K, Kitazono T, et al
    Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).
    Lancet Neurol. 2019;18:238-247.
    >> Share

  85. MELIS M, Ricci S, Toni D
    Optimal stroke prevention in patients with PFO.
    Lancet Neurol. 2019;18:231.
    >> Share

  86. DICHGANS M
    Dementia risk after transient ischaemic attack and stroke.
    Lancet Neurol. 2019;18:223-225.
    >> Share

  87. HANKEY GJ
    Prasugrel or clopidogrel for long-term secondary stroke prevention?
    Lancet Neurol. 2019;18:222-223.
    >> Share

  88. PENDLEBURY ST, Rothwell PM
    Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
    Lancet Neurol. 2019;18:248-258.
    >> Share

    February 2019
  89. BROTT TG, Calvet D, Howard G, Gregson J, et al
    Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data.
    Lancet Neurol. 2019 Feb 6. pii: S1474-4422(19)30028.
    >> Share

    January 2019
  90. WARDLAW JM, Bath PM
    Stroke research in 2018: extended time windows, refined benefit, and lifestyle prevention targets.
    Lancet Neurol. 2019;18:2-3.
    >> Share

    December 2018
  91. THIEBAUT AM, Gauberti M, Ali C, Martinez De Lizarrondo S, et al
    The role of plasminogen activators in stroke treatment: fibrinolysis and beyond.
    Lancet Neurol. 2018;17:1121-1132.
    >> Share

  92. SCHEITZ JF, Nolte CH, Doehner W, Hachinski V, et al
    Stroke-heart syndrome: clinical presentation and underlying mechanisms.
    Lancet Neurol. 2018;17:1109-1120.
    >> Share

    November 2018
  93. SEIFFGE DJ, Werring DJ, Paciaroni M, Dawson J, et al
    Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.
    Lancet Neurol. 2018 Nov 8. pii: S1474-4422(18)30356.
    >> Share

  94. CAMPBELL BCV, Majoie CBLM, Albers GW, Menon BK, et al
    Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.
    Lancet Neurol. 2018 Nov 6. pii: S1474-4422(18)30314.
    >> Share

  95. WARACH S
    Patients with large brain infarcts might also benefit from thrombectomy.
    Lancet Neurol. 2018 Nov 6. pii: S1474-4422(18)30357.
    >> Share

    October 2018
  96. MEIER B
    Optimal stroke prevention in patients with patent foramen ovale.
    Lancet Neurol. 2018 Oct 16. pii: S1474-4422(18)30369.
    >> Share

  97. ROMAN LS, Menon BK, Blasco J, Hernandez-Perez M, et al
    Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.
    Lancet Neurol. 2018;17:895-904.
    >> Share

  98. BROWN MM, Bonati LH
    The fate of severe restenosis after carotid interventions - Authors' reply.
    Lancet Neurol. 2018;17:843-844.
    >> Share

  99. ALBERS GW
    Endovascular thrombectomy in patients with large infarctions: reasons for restraint.
    Lancet Neurol. 2018;17:836-837.
    >> Share

    September 2018
  100. KASNER SE, Swaminathan B, Lavados P, Sharma M, et al
    Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Lancet Neurol. 2018 Sep 28. pii: S1474-4422(18)30319.
    >> Share

  101. EKKER MS, Boot EM, Singhal AB, Tan KS, et al
    Epidemiology, aetiology, and management of ischaemic stroke in young adults.
    Lancet Neurol. 2018;17:790-801.
    >> Share

  102. LIU T, Ding Y, Wen A
    Traditional Chinese medicine for ischaemic stroke.
    Lancet Neurol. 2018;17:745.
    >> Share

    August 2018
  103. DENNIS M
    Pharyngeal stimulation after stroke: more evidence is needed.
    Lancet Neurol. 2018 Aug 28. pii: S1474-4422(18)30312.
    >> Share

  104. DZIEWAS R, Stellato R, van der Tweel I, Walther E, et al
    Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial.
    Lancet Neurol. 2018 Aug 28. pii: S1474-4422(18)30255.
    >> Share

  105. AL-SHAHI SALMAN R, Frantzias J, Lee RJ, Lyden PD, et al
    Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.
    Lancet Neurol. 2018 Aug 14. pii: S1474-4422(18)30253.
    >> Share

  106. WOO D, Anderson CD, Maguire J, Fornage M, et al
    Top research priorities for stroke genetics.
    Lancet Neurol. 2018;17:663-665.
    >> Share

    July 2018
  107. BUSHNELL C, Howard VJ, Lisabeth L, Caso V, et al
    Sex differences in the evaluation and treatment of acute ischaemic stroke.
    Lancet Neurol. 2018;17:641-650.
    >> Share

  108. CHATURVEDI S
    Is surveillance for restenosis justified after carotid revascularisation?
    Lancet Neurol. 2018;17:570-571.
    >> Share

    June 2018
  109. MORGAN J
    A new life after stroke.
    Lancet Neurol. 2018 Jun 25. pii: S1474-4422(18)30249.
    >> Share

  110. MAZZUCCO S, Li L, Binney L, Rothwell PM, et al
    Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.
    Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30167.
    >> Share

  111. QUADRI M, Mandemakers W, Grochowska MM, Masius R, et al
    LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
    Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30179.
    >> Share

  112. THALER D
    Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack.
    Lancet Neurol. 2018 Jun 6. pii: S1474-4422(18)30198.
    >> Share

  113. WILSON D, Ambler G, Shakeshaft C, Brown MM, et al
    Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
    Lancet Neurol. 2018;17:539-547.
    >> Share

  114. KIM BJ, Lee EJ, Kwon SU, Park JH, et al
    Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
    Lancet Neurol. 2018;17:509-518.
    >> Share

  115. CORDONNIER C
    Balancing risks versus benefits of anticoagulants in stroke prevention.
    Lancet Neurol. 2018;17:487-488.
    >> Share

  116. AL-SHAHI SALMAN R
    A new era for comorbid cerebral ischaemia and haemorrhage.
    Lancet Neurol. 2018;17:482-483.
    >> Share

  117. THE LANCET NEUROLOGY
    Strong alliances to improve stroke care.
    Lancet Neurol. 2018;17:481.
    >> Share

    May 2018
  118. BONATI LH, Gregson J, Dobson J, McCabe DJH, et al
    Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial.
    Lancet Neurol. 2018 May 31. pii: S1474-4422(18)30195.
    >> Share

  119. SCHWAMM LH
    Disruptive innovation in acute stroke systems of care.
    Lancet Neurol. 2018 May 25. pii: S1474-4422(18)30197.
    >> Share

    April 2018
  120. ROTHWELL PM
    Clinical innovation in stroke: getting the simple things right.
    Lancet Neurol. 2018 Apr 10. pii: S1474-4422(18)30113.
    >> Share


  121. Yogeshwar Kalkonde.
    Lancet Neurol. 2018;17:305.
    >> Share

  122. CHARLIER P, Appenzeller O, Deo S, Perciaccante A, et al
    Hemiplegic migraine and stroke in Mary Shelley.
    Lancet Neurol. 2018;17:305.
    >> Share

    February 2018
  123. GALOVIC M, Dohler N, Keezer MR, Duncan JS, et al
    The SeLECT score is useful to predict post-stroke epilepsy.
    Lancet Neurol. 2018 Feb 15. pii: S1474-4422(18)30075.
    >> Share

  124. GALOVIC M, Dohler N, Erdelyi-Canavese B, Felbecker A, et al
    Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study.
    Lancet Neurol. 2018;17:143-152.
    >> Share

  125. FINSTERER J
    The SeLECT score is inappropriate to predict post-stroke epilepsy.
    Lancet Neurol. 2018;17:106-107.
    >> Share

    January 2018
  126. RODRIGUES MA, Samarasekera N, Lerpiniere C, Humphreys C, et al
    The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study.
    Lancet Neurol. 2018 Jan 10. pii: S1474-4422(18)30006.
    >> Share

  127. CAMPBELL BCV, van Zwam WH, Goyal M, Menon BK, et al
    Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.
    Lancet Neurol. 2018;17:47-53.
    >> Share

  128. DINSMORE J
    HERMES: a helpful messenger in the anaesthesia for thrombectomy debate?
    Lancet Neurol. 2018;17:21-23.
    >> Share

    November 2017
  129. CORLEY J
    Telestroke: India's solution to a public health-care crisis.
    Lancet Neurol. 2017 Nov 29. pii: S1474-4422(17)30423.
    >> Share

  130. BURTON A
    Trying to change the stroke landscape in Nigeria.
    Lancet Neurol. 2017;16:869-870.
    >> Share

    October 2017
  131. STINEAR CM
    Prediction of motor recovery after stroke: advances in biomarkers.
    Lancet Neurol. 2017;16:826-836.
    >> Share

  132. WILSON L, Stewart W, Dams-O'Connor K, Diaz-Arrastia R, et al
    The chronic and evolving neurological consequences of traumatic brain injury.
    Lancet Neurol. 2017;16:813-825.
    >> Share

  133. PLOUGHMAN M
    A new era of multiple sclerosis rehabilitation: lessons from stroke.
    Lancet Neurol. 2017;16:768-769.
    >> Share

    September 2017
  134. FINSTERER J
    Low risk of ischaemic stroke in hyperhomocysteinaemia.
    Lancet Neurol. 2017;16:682-683.
    >> Share

  135. SPENCE JD, Yi Q, Hankey GJ
    B vitamins in stroke prevention: time to reconsider.
    Lancet Neurol. 2017;16:750-760.
    >> Share

  136. VAN VELUW SJ, Shih AY, Smith EE, Chen C, et al
    Detection, risk factors, and functional consequences of cerebral microinfarcts.
    Lancet Neurol. 2017;16:730-740.
    >> Share

    August 2017
  137. ANDERSON CS
    NOR-TEST-ing tenecteplase in acute ischaemic stroke.
    Lancet Neurol. 2017 Aug 8. pii: S1474-4422(17)30277.
    >> Share

  138. LOGALLO N, Novotny V, Assmus J, Kvistad CE, et al
    Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Lancet Neurol. 2017 Aug 2. pii: S1474-4422(17)30253.
    >> Share

  139. MAEGELE M, Schochl H, Menovsky T, Marechal H, et al
    Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management.
    Lancet Neurol. 2017;16:630-647.
    >> Share

  140. SIHVONEN AJ, Sarkamo T, Leo V, Tervaniemi M, et al
    Music-based interventions in neurological rehabilitation.
    Lancet Neurol. 2017;16:648-660.
    >> Share

    July 2017
  141. WACHTER R, Groschel K
    Atrial fibrillation in high-risk patients with ischaemic stroke - Authors' reply.
    Lancet Neurol. 2017;16:498.
    >> Share

  142. KNECHT S, Petsch S, Studer B
    Atrial fibrillation in high-risk patients with ischaemic stroke.
    Lancet Neurol. 2017;16:498.
    >> Share

    May 2017
  143. BERGE E, Salman RA, van der Worp HB, Stapf C, et al
    Increasing value and reducing waste in stroke research.
    Lancet Neurol. 2017;16:399-408.
    >> Share

    March 2017
  144. HESS DC, Wechsler LR, Clark WM, Savitz SI, et al
    Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2017 Mar 17. pii: S1474-4422(17)30046.
    >> Share

  145. DAVALOS A, Cobo E, Molina CA, Chamorro A, et al
    Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.
    Lancet Neurol. 2017 Mar 16. pii: S1474-4422(17)30047.
    >> Share

  146. FASSBENDER K, Grotta JC, Walter S, Grunwald IQ, et al
    Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.
    Lancet Neurol. 2017;16:227-237.
    >> Share

  147. ELKINS J, Veltkamp R, Montaner J, Johnston SC, et al
    Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Lancet Neurol. 2017;16:217-226.
    >> Share

  148. TATLISUMAK T
    Can natalizumab be beneficial in acute ischaemic stroke?
    Lancet Neurol. 2017;16:176-177.
    >> Share

    February 2017
  149. AMARENCO P, Albers GW, Denison H, Easton JD, et al
    Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Lancet Neurol. 2017 Feb 23. pii: S1474-4422(17)30038.
    >> Share

  150. WACHTER R, Groschel K, Gelbrich G, Hamann GF, et al
    Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.
    Lancet Neurol. 2017 Feb 7. pii: S1474-4422(17)30002.
    >> Share

  151. BRACARD S, Ducrocq X, Guillemin F, Moulin T, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke - Authors' reply.
    Lancet Neurol. 2017;16:104.
    >> Share

  152. BADHIWALA JH, Nassiri F, Kulkarni AV, Spears J, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103.
    >> Share

  153. MORELLI N, Rota E, Michieletti E, Guidetti D, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103-104.
    >> Share

    November 2016
  154. KELLY PJ, Albers GW, Chatzikonstantinou A, De Marchis GM, et al
    Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.
    Lancet Neurol. 2016;15:1238-1247.
    >> Share

  155. HANLEY DF, Thompson RE, Muschelli J, Rosenblum M, et al
    Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
    Lancet Neurol. 2016;15:1228-1237.
    >> Share

  156. KIM AS
    Stroke risk prediction after transient ischaemic attack.
    Lancet Neurol. 2016;15:1199-1200.
    >> Share

    October 2016
  157. TANG M, Ryman DC, McDade E, Jasielec MS, et al
    Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
    >> Share

    August 2016
  158. BERKHEMER OA, Dippel DW
    Intra-arterial therapy for acute ischaemic stroke.
    Lancet Neurol. 2016 Aug 23. pii: S1474-4422(16)30197.
    >> Share

  159. THE LANCET NEUROLOGY
    The shared burden of stroke and dementia.
    Lancet Neurol. 2016;15:891.
    >> Share

    July 2016
  160. SEITZ RJ
    The pros and cons of intravenous thrombolysis in stroke.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30159.
    >> Share

  161. RUDD AG
    Can emergency stroke care be delivered in an ambulance?
    Lancet Neurol. 2016 Jul 15. pii: S1474-4422(16)30162.
    >> Share

  162. FRASER JF
    Standardisation of research strategies in acute ischaemic stroke.
    Lancet Neurol. 2016;15:784-5.
    >> Share

  163. AL-SHAHI SALMAN R, McGoohan K, Rodrigues M, Dichgans M, et al
    Dementia after stroke due to intracerebral haemorrhage.
    Lancet Neurol. 2016;15:779-80.
    >> Share

    June 2016
  164. SILVER B
    Virtual reality versus reality in post-stroke rehabilitation.
    Lancet Neurol. 2016 Jun 27. pii: S1474-4422(16)30126.
    >> Share

  165. HACHINSKI V, Azarpazhooh MR
    Stroke is a burdensome but preventable brain disorder.
    Lancet Neurol. 2016 Jun 9. pii: S1474-4422(16)30120.
    >> Share

  166. KIECHL S, Willeit J
    Alteplase in acute ischaemic stroke: no time to slow down.
    Lancet Neurol. 2016 Jun 8. pii: S1474-4422(16)30095.
    >> Share

  167. HACHINSKI V, Sposato LA, Kapral M
    Preventing both stroke and dementia.
    Lancet Neurol. 2016;15:659.
    >> Share

  168. BRAYNE C, Wu YT
    Preventing both stroke and dementia - Authors' reply.
    Lancet Neurol. 2016;15:659.
    >> Share

  169. VON KUMMER R
    Early CT Score to establish stroke treatment.
    Lancet Neurol. 2016;15:651-3.
    >> Share

  170. CORALLI A, Perciaccante A
    Leonardo's recurrent stroke?
    Lancet Neurol. 2016;15:667.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016